Featured Research

from universities, journals, and other organizations

NYU Researchers Discover Mechanism Linking Color Vision And Cancer Genes

Date:
September 10, 2005
Source:
New York University
Summary:
Biologists at New York University have discovered a system by which a random choice between two distinct cellular fates in the fruit fly eye becomes firmly established. Surprisingly, the genes involved are known 'tumor suppressor genes', i.e. genes that are inactivated in some forms of cancer due to uncontrolled cell proliferation.

Biologists at New York University have discovered a system by which arandom choice between two distinct cellular fates in the fruit fly eyebecomes firmly established. Surprisingly, the genes involved are known'tumor suppressor genes', i.e. genes that are inactivated in some formsof cancer due to uncontrolled cell proliferation. Because the fly eyeis highly amenable to genetic analysis, these findings, published inthe latest issue of Cell, could help decipher the mechanisms by whichgenes that control cell proliferation and cell growth are themselvesregulated.

In this study, researchers from Dr. Claude Desplan's laboratory inthe Center for Developmental Genetics at NYU Biology used the fly eyeto understand the mechanism that affects the choice betweenphotoreceptors that allows color discrimination: A given colorphotoreceptor can randomly decide to express a blue, or a greenphotopigment, but expressing both would lead to sensory confusion.Therefore, a switch mechanism ensures that photoreceptors make anunambiguous decision. Interestingly, the genes involved in this switchappear to be part of a tumor suppressor pathway.

Researchers have recently uncovered processes by which groupsof genes work together to affect the number and size of cells. Thesegenes are often affected in cancers where cells proliferate in anuncontrolled manner. Less clear, however, are the upstream mechanismsthat control this genetic activity: Understanding the regulation ofthese pathways is essential as it would enhance our ability to controlprocesses by which cancer cells replicate or die. Although thephotoreceptors have long completed their last cell division, theyappear to re-utilize the genetic pathways known to control cellproliferation and cell size to achieve a stable state.

"These genes form a bistable loop that insures a robustcommitment of color photoreceptors that does allow ambiguity," saidDesplan, the study's corresponding author. "This represents anunexpected role for genes known to control cell proliferation and cellgrowth."

###

The research was supported, in part, by a grant from the National Institutes of Health.


Story Source:

The above story is based on materials provided by New York University. Note: Materials may be edited for content and length.


Cite This Page:

New York University. "NYU Researchers Discover Mechanism Linking Color Vision And Cancer Genes." ScienceDaily. ScienceDaily, 10 September 2005. <www.sciencedaily.com/releases/2005/09/050910091409.htm>.
New York University. (2005, September 10). NYU Researchers Discover Mechanism Linking Color Vision And Cancer Genes. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2005/09/050910091409.htm
New York University. "NYU Researchers Discover Mechanism Linking Color Vision And Cancer Genes." ScienceDaily. www.sciencedaily.com/releases/2005/09/050910091409.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins